Home   >  
Ion Channel/Membrane Transporter
  • Neuro Signaling Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Myosmine Chemical Structure
BCP47943 Myosmine 532-12-7
Myosmine, a specific tobacco alkaloid in nuts and nut products, has low affinity for a4b2 nicotinic acetylcholinergic receptors (nAChR) with a Ki of 3300 nM.
NS1738 Chemical Structure
BCP46794 NS1738 501684-93-1
NS1738 is a α7 positive allosteric modulator.
Anagyrin Chemical Structure
BCP44368 Anagyrin 486-89-5
Anagyrine is an alkaloid that has been found in L. albus and has nematocidal and anticancer activities.
ABT-418 hydrochloride Chemical Structure
BCP38433 ABT-418 hydrochloride 147388-83-8
ABT-418 hydrochloride is a neuronal nicotinic acetylcholine receptor agonist.
4BP-TQS Chemical Structure
BCP37825 4BP-TQS 360791-49-7
4BP-TQS is an allosteric agonist of α7 subunit-containing neuronal nicotinic acetylcholine receptors (nAChRs).
PSEM 89S TFA Chemical Structure
BCP35173 PSEM 89S TFA 1336913-03-1
PSEM 89S TFA is a selective and brain penetrant agonists for the resulting ion channels. PSEM 89S TFA is orthogonally selective for Q79G and L141F, respectively.
CCMI Chemical Structure
BCP35052 CCMI 917837-54-8
CCMI is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction.
nAChR agonist 1 Chemical Structure
BCP33344 nAChR agonist 1 1394371-75-5
nAChR agonist 1 is a potent, brain-permeable, and orally efficacious positive allosteric modulator of α7 nicotinic acetylcholine receptor (α7 nAChR).
Facinicline hydrochloride Chemical Structure
BCP33359 Facinicline hydrochloride 677305-02-1
PNU-282987 S enantiomer free base Chemical Structure
BCP25435 PNU-282987 S enantiomer free base 737727-12-7
PNU-282987 is a highly selective α7 nAChR agonist (Ki = 26 nM) displaying negligible blockade of α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM).
12下一页共 20 条记录 1 / 2 页